Đang tải…
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
| Những tác giả chính: | , , |
|---|---|
| Định dạng: | Online Bài viết Texto |
| Ngôn ngữ: | English |
| Được phát hành: |
Dove Medical Press
2014
|
| Những chủ đề: | |
| Truy cập trực tuyến: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://www.ncbi.nlm.nih.gov/pubmed/27471700 http://dx.doi.org/10.2147/ITT.S40121 |